160 related articles for article (PubMed ID: 3430066)
21. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
[TBL] [Abstract][Full Text] [Related]
22. 5 beta-hydroxylation by the liver. Identification of 3,5,7-trihydroxy nor-bile acids as new major biotransformation products of 3,7-dihydroxy nor-bile acids in rodents.
Schteingart CD; Hagey LR; Setchell KD; Hofmann AF
J Biol Chem; 1993 May; 268(15):11239-46. PubMed ID: 8496179
[TBL] [Abstract][Full Text] [Related]
23. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
[TBL] [Abstract][Full Text] [Related]
24. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC.
Roda A; Minutello A; Angellotti MA; Fini A
J Lipid Res; 1990 Aug; 31(8):1433-43. PubMed ID: 2280184
[TBL] [Abstract][Full Text] [Related]
25. Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat.
Zouboulis-Vafiadis I; Dumont M; Erlinger S
Am J Physiol; 1982 Sep; 243(3):G208-13. PubMed ID: 7114264
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of new bile acid analogues and their metabolism in the hamster: 3 alpha, 6 alpha-dihydroxy-6 beta-methyl-5 beta-cholanoic acid and 3 alpha, 6 beta-dihydroxy-6 alpha-methyl-5 beta-cholanoic acid.
Matoba N; Mosbach EH; Cohen BI; Une M; McSherry CK
J Lipid Res; 1989 Jul; 30(7):1005-14. PubMed ID: 2794784
[TBL] [Abstract][Full Text] [Related]
27. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
Kubaska WM; Gurley EC; Hylemon PB; Heuman DM; Mosbach EH; Vlahcevic ZR
Biochim Biophys Acta; 1987 Aug; 920(3):195-204. PubMed ID: 3607077
[TBL] [Abstract][Full Text] [Related]
28. Identification of 3 beta, 7 beta-dihydroxy-5 beta-cholan-24-oic acid in serum from patients treated with ursodeoxycholic acid.
Maeda M; Ohama H; Takeda H; Yabe M; Nambu M; Namihisa T
J Lipid Res; 1984 Jan; 25(1):14-26. PubMed ID: 6707518
[TBL] [Abstract][Full Text] [Related]
29. Cholestasis, metabolism and biliary lipid secretion during perfusion of rat liver with different bile salts.
Baumgartner U; Schölmerich J; Leible P; Farthmann EH
Biochim Biophys Acta; 1992 Apr; 1125(2):142-9. PubMed ID: 1571357
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent derivatives of bile salts. II. Suitability of NBD-amino derivatives of bile salts for the study of biological transport.
Schramm U; Dietrich A; Schneider S; Buscher HP; Gerok W; Kurz G
J Lipid Res; 1991 Nov; 32(11):1769-79. PubMed ID: 1770296
[TBL] [Abstract][Full Text] [Related]
31. Intestinal absorption and metabolism of homoursodeoxycholic acid in rats.
Kuramoto T; Moriwaki S; Kawamoto K; Hoshita T
J Pharmacobiodyn; 1987 Jul; 10(7):309-16. PubMed ID: 3694424
[TBL] [Abstract][Full Text] [Related]
32. 23-Methyl-3 alpha,7 beta-dihydroxy-5 beta-cholan-24-oic acid: dose-response study of biliary secretion in rat.
Roda A; Aldini R; Grigolo B; Simoni P; Roda E; Pellicciari R; Lenzi PL; Natalini B
Hepatology; 1988; 8(6):1571-6. PubMed ID: 3192170
[TBL] [Abstract][Full Text] [Related]
33. Novel derivatives of 3 alpha,7 alpha-dihydroxy-5 beta-cholan-24-oic acid (chenodeoxycholic acid) and 3 alpha,7 beta-dihydroxy-5 beta-cholan-24-oic acid (ursodeoxycholic acid).
Kritchevsky D; Poli G; Scolastico C; Sirtori CR
Steroids; 1986 Jan; 47(1):41-8. PubMed ID: 3810698
[TBL] [Abstract][Full Text] [Related]
34. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
Yanaura S; Izuka A; Ishikawa S
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
[TBL] [Abstract][Full Text] [Related]
35. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification.
Aldini R; Roda A; Montagnani M; Cerrè C; Pellicciari R; Roda E
Steroids; 1996 Oct; 61(10):590-7. PubMed ID: 8910972
[TBL] [Abstract][Full Text] [Related]
36. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of 7 beta-alkyl chenodeoxycholic acid analogs and their effect on cholesterol metabolism in hamsters.
Une M; Yamanaga K; Mosbach EH; Tsujimura K; Hoshita T
J Lipid Res; 1990 Jun; 31(6):1015-21. PubMed ID: 2373951
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
39. Effect of natural and structurally modified bile acids on cholesterol metabolizing enzymes in rat liver microsomes.
Crestani M; De Fabiani E; Malavasi B; Cancellieri M; Galli G; Bosisio E
Chem Phys Lipids; 1989 Oct; 51(2):119-26. PubMed ID: 2590949
[TBL] [Abstract][Full Text] [Related]
40. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities.
Armstrong MJ; Carey MC
J Lipid Res; 1982 Jan; 23(1):70-80. PubMed ID: 7057113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
